<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Mead Johnson Nutrition Company</title>
	<atom:link href="http://www.stockbloghub.com/tag/mead-johnson-nutrition-company/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(BMY) Company News for January 04, 2012 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2012/01/08/bmy-company-news-for-january-04-2012-corporate-summary/89648</link>
		<comments>http://www.stockbloghub.com/2012/01/08/bmy-company-news-for-january-04-2012-corporate-summary/89648#comments</comments>
		<pubDate>Mon, 09 Jan 2012 04:48:12 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[China Petroleum & Chemical Corporation]]></category>
		<category><![CDATA[Devon Energy Corporation]]></category>
		<category><![CDATA[DVN]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[MGIC Investment Corporation]]></category>
		<category><![CDATA[MJN]]></category>
		<category><![CDATA[MTG]]></category>
		<category><![CDATA[Rambus Inc.]]></category>
		<category><![CDATA[RMBS]]></category>
		<category><![CDATA[SNP]]></category>
		<category><![CDATA[TEVA]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Limited]]></category>
		<category><![CDATA[United States Steel Corporation]]></category>
		<category><![CDATA[X]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89648</guid>
		<description><![CDATA[•    Share prices of natural gas producer Devon Energy Corp (NYSE:DVN) gained 6.63% after the company announced it would sell a stake in five of its exploratory projects across the U.S., to Sinopec International Petroleum Exploration &#38; Production, a unit of China Petroleum &#38; Chemical (NYSE:SNP) for $2.2 billion •    Pediatric nutrition company Mead Johnson Nutrition Co.’s (NYSE:MJN) shares advanced 3.81% to close at $71.35 after U.S. health officials confirmed they hadn’t found deadly bacteria in cans of the company&#8217;s Enfamil baby formula •    Shares of technology-licensing company Rambus Inc. (NASDAQ:RMBS) increased 7.42% to close at $8.11 after the company raised its forecast for the fourth quarter •    Steel producer U.S. Steel Corp.’s (NYSE:X) shares rose 6.46% after a better U.S. manufacturing activity report, striking a six-month high during the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/08/bmy-company-news-for-january-04-2012-corporate-summary/89648/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COP) Company News for December 28, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/12/29/cop-company-news-for-december-28-2011-corporate-summary/89325</link>
		<comments>http://www.stockbloghub.com/2011/12/29/cop-company-news-for-december-28-2011-corporate-summary/89325#comments</comments>
		<pubDate>Thu, 29 Dec 2011 15:58:36 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Major Integrated Oil & Gas]]></category>
		<category><![CDATA[ConocoPhillips]]></category>
		<category><![CDATA[COP]]></category>
		<category><![CDATA[END]]></category>
		<category><![CDATA[Endeavour International Corporation]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[MJN]]></category>
		<category><![CDATA[PARL]]></category>
		<category><![CDATA[Parlux Fragrances Inc]]></category>
		<category><![CDATA[PERF]]></category>
		<category><![CDATA[Perfumania Holdings Inc]]></category>
		<category><![CDATA[Sears Holdings Corporation]]></category>
		<category><![CDATA[SHLD]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89325</guid>
		<description><![CDATA[•    Share prices of oil and gas company Endeavour International Corp (NYSE:END) increased 24.06% after the company agreed to purchase a stake in three oil fields from ConocoPhillips&#8217; (NYSE:COP) for $330 million •    Retailer Sears Holdings Corp.’s (NASDAQ:SHLD) shares plummeted 27.20% to close at $33.38 after it confirmed plans to shut 100 stores. Sears also reported continuing sales troubles in the current quarter •    Oil and gas company Magnum Hunter Resources Corp (NYSE:MHR) raised its production outlook for both the current and coming year. Following this development, shares of the company advanced 17.13% to close at $5.47 •    Shares of fragrance maker Perlux Fragrances Inc. (NASDAQ:PARL) rocketed up 71.18% to $5.94 after Perfumania Holdings Inc. (NASDAQ:PERF) said it would acquire Perlux in a deal worth $170 million •    Pediatric nutrition ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/29/cop-company-news-for-december-28-2011-corporate-summary/89325/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AMZN) Company News for January 28, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/01/29/amzn-company-news-for-january-28-2011-corporate-summary/65970</link>
		<comments>http://www.stockbloghub.com/2011/01/29/amzn-company-news-for-january-28-2011-corporate-summary/65970#comments</comments>
		<pubDate>Sat, 29 Jan 2011 22:48:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Catalog & Mail Order Houses]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Amazon.com Inc]]></category>
		<category><![CDATA[AMZN]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[L-3 Communications Holdings Inc]]></category>
		<category><![CDATA[LLL]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MJN]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[POT]]></category>
		<category><![CDATA[Potash Corporation of Saskatchewan Inc]]></category>
		<category><![CDATA[QCOM]]></category>
		<category><![CDATA[QUALCOMM Inc]]></category>
		<category><![CDATA[UA]]></category>
		<category><![CDATA[Under Armour Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=65970</guid>
		<description><![CDATA[• Microsoft (NASDAQ:MSFT) reported Q2 EPS of $0.77, above the Zacks Consensus Estimate of $0.55 per share. Revenues for the quarter were $19.95 billion, well above the Zacks Consensus Estimate of $16.073 billion • Amazon.com (NASDAQ:AMZN) reported Q4 EPS of $0.91, ahead of the Zacks Consensus Estimate of $0.76 per share. Revenues for the quarter rose 36% year-over-year to $12.95 billion, above the Zacks Consensus Estimate of $9.281 billion • Under Armour (NYSE:UA) reported Q4 EPS of $0.44, well ahead of the Zacks Consensus Estimate of $0.21 per share. Revenues for the quarter rose 36% year-over-year to $301.2 million, above the Zacks Consensus Estimate of $284 million • L-3 Communications Holdings (NYSE:LLL) reported Q4 EPS of $2.37, ahead of the Zacks Consensus Estimate of $1.89 per share. Revenues for the quarter rose 1.1% year-over-year ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/29/amzn-company-news-for-january-28-2011-corporate-summary/65970/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BMY) Bristol-Myers Squibb Company Surpasses Earnings Estimates</title>
		<link>http://www.stockbloghub.com/2010/01/29/bmy-bristol-myers-squibb-company-surpasses-earnings-estimates/26388</link>
		<comments>http://www.stockbloghub.com/2010/01/29/bmy-bristol-myers-squibb-company-surpasses-earnings-estimates/26388#comments</comments>
		<pubDate>Sat, 30 Jan 2010 00:51:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AstraZeneca plc]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[MJN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=26388</guid>
		<description><![CDATA[This morning, Bristol-Myers Squibb Company (BMY) reported fourth quarter and full-year results for fiscal 2009. Quarterly Results The company earned 47 cents per share in the fourth quarter as opposed to 40 cents in the year-ago quarter. The Zacks Consensus Estimate for the quarter was 43 cents. Net sales for the quarter came in at $5,033 million against $4,542 million in the year-ago quarter, representing an increase of 10.8%. The increase was primarily attributable to strong sales of Plavix, an anti-platelet blood thinner indicated to reduce the risk of heart attack in patients with atherosclerosis (the build-up of plaque and hardening of the arteries), as well as robust sales of HIV treatment drugs Reyataz and Sustiva. Global sales of Plavix in the quarter rose 10% to $1.62 billion. Sales of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/29/bmy-bristol-myers-squibb-company-surpasses-earnings-estimates/26388/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DD) A Very Busy Week Ahead &#8211; Earnings Preview</title>
		<link>http://www.stockbloghub.com/2010/01/23/dd-a-very-busy-week-ahead-earnings-preview/25730</link>
		<comments>http://www.stockbloghub.com/2010/01/23/dd-a-very-busy-week-ahead-earnings-preview/25730#comments</comments>
		<pubDate>Sat, 23 Jan 2010 20:46:07 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Chemicals - Major Diversified]]></category>
		<category><![CDATA[3M Company]]></category>
		<category><![CDATA[Altria Group Inc.]]></category>
		<category><![CDATA[BA]]></category>
		<category><![CDATA[Boeing Company]]></category>
		<category><![CDATA[CAT]]></category>
		<category><![CDATA[Caterpillar Inc.]]></category>
		<category><![CDATA[Chevron Corporation]]></category>
		<category><![CDATA[Corning Inc]]></category>
		<category><![CDATA[CVX]]></category>
		<category><![CDATA[DD]]></category>
		<category><![CDATA[EI DuPont de Nemours & Company]]></category>
		<category><![CDATA[EL]]></category>
		<category><![CDATA[Estee Lauder Companies Inc.]]></category>
		<category><![CDATA[FPL]]></category>
		<category><![CDATA[FPL Group Inc.]]></category>
		<category><![CDATA[GLW]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[MeadWestvaco Corporation]]></category>
		<category><![CDATA[MJN]]></category>
		<category><![CDATA[MMM]]></category>
		<category><![CDATA[MO]]></category>
		<category><![CDATA[MWV]]></category>
		<category><![CDATA[PG]]></category>
		<category><![CDATA[Procter & Gamble Company]]></category>
		<category><![CDATA[SII]]></category>
		<category><![CDATA[Smith International Inc.]]></category>
		<category><![CDATA[United Technologies Corporation]]></category>
		<category><![CDATA[UTX]]></category>
		<category><![CDATA[Verizon Communications Inc.]]></category>
		<category><![CDATA[VZ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=25730</guid>
		<description><![CDATA[Earnings Preview 1/22/10 Next week is the heart of the 4Q09 earnings season. There will be a total of 503 firms reporting including 136 members of the S&#38;P 500, and fully one third of the Dow 30. These will include such bellwethers as DuPont (DD), Johnson &#38; Johnson (JNJ), Verizon (VZ), Boeing (BA), Caterpillar (CAT), United Technologies (UTX), 3M (MMM), Altria (MO), Procter &#38; Gamble (PG) and Chevron (CVX). And those are just the Dow names reporting results. Early in the week, the economic data on housing will be front and center, while the middle of the week brings a Fed meeting, and at the end of the week we get the first look at fourth quarter GDP. All in all, a very busy week coming up. Monday • Data on ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/23/dd-a-very-busy-week-ahead-earnings-preview/25730/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BMY) Bristol-Myers Squibb Cuts 2009 Outlook</title>
		<link>http://www.stockbloghub.com/2009/12/27/bmy-bristol-myers-squibb-cuts-2009-outlook/23580</link>
		<comments>http://www.stockbloghub.com/2009/12/27/bmy-bristol-myers-squibb-cuts-2009-outlook/23580#comments</comments>
		<pubDate>Sun, 27 Dec 2009 23:19:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[MJN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23580</guid>
		<description><![CDATA[Yesterday, Bristol-Myers Squibb (BMY) lowered its fiscal 2009 outlook as a result of the split-off of pediatric nutrition company Mead Johnson Nutrition Co (MJN). Bristol-Myers expects earnings per share from continuing operations in the range of $1.75 -$1.80, down from its earlier guidance of $2.00 &#8211; $2.05. Earlier, in Nov, Bristol-Myers decided to split off its 83.1% holding in Mead Johnson. Mead Johnson completed a public offering in Feb 2009. Since then, its shares have risen considerably. Following the completion of the spin-off, Bristol-Myers expects the transaction to be net cash flow positive to its biopharmaceutical business and accretive to earnings beginning in 2010. Earlier this month, the share swap ratio between the two companies was amended to 0.6313 shares of Mead Johnson per 1 Bristol-Myers common share from the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/27/bmy-bristol-myers-squibb-cuts-2009-outlook/23580/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BMY) Bristol-Myers Squibb Sets Swap Offer Rate</title>
		<link>http://www.stockbloghub.com/2009/12/17/bmy-bristol-myers-squibb-sets-swap-offer-rate/23149</link>
		<comments>http://www.stockbloghub.com/2009/12/17/bmy-bristol-myers-squibb-sets-swap-offer-rate/23149#comments</comments>
		<pubDate>Fri, 18 Dec 2009 01:21:42 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[MJN]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23149</guid>
		<description><![CDATA[Bristol-Myers Squibb Co. (BMY), which intends to split its 83.1% stake in the Nutritional segment to concentrate exclusively on its biopharmaceutical business, announced that it will offer 0.6313 shares of Mead Johnson Nutrition Co.’s (MJN) common stock for each Bristol-Myers share in the exchange offer. The Nutritional segment operates under its subsidiary Mead Johnson and develops infant formulas such as Enfamil. The offer, which will witness Bristol-Myers exchange up to 170 million shares of its Nutritional segment, is set to end on Dec 17, 2009. The offer will see Bristol-Myers accepting a maximum of 269.29 million shares of its common stock for exchange. The swap offer will be subject to proration if it is over-subscribed. In the event of the offer being consummated but not fully subscribed, Bristol-Myers intends to ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/17/bmy-bristol-myers-squibb-sets-swap-offer-rate/23149/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CIEN) Ciena Corporation is Removed From The S&amp;P 500</title>
		<link>http://www.stockbloghub.com/2009/12/15/cien-ciena-corporation-is-removed-from-the-sp-500/22926</link>
		<comments>http://www.stockbloghub.com/2009/12/15/cien-ciena-corporation-is-removed-from-the-sp-500/22926#comments</comments>
		<pubDate>Wed, 16 Dec 2009 05:16:52 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Communication Equipment]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Blyth]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[BTH]]></category>
		<category><![CDATA[CIEN]]></category>
		<category><![CDATA[Ciena Corporation]]></category>
		<category><![CDATA[CLF]]></category>
		<category><![CDATA[Cliffs Natural Resources Inc.]]></category>
		<category><![CDATA[Convergys Corporation]]></category>
		<category><![CDATA[CVG]]></category>
		<category><![CDATA[DYN]]></category>
		<category><![CDATA[Dynegy Inc.]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[KB Home]]></category>
		<category><![CDATA[KBH]]></category>
		<category><![CDATA[MBI]]></category>
		<category><![CDATA[MBIA Inc.]]></category>
		<category><![CDATA[Mead Johnson Nutrition Company]]></category>
		<category><![CDATA[MJN]]></category>
		<category><![CDATA[Ross Stores Inc.]]></category>
		<category><![CDATA[ROST]]></category>
		<category><![CDATA[SAI]]></category>
		<category><![CDATA[SAIC]]></category>
		<category><![CDATA[V]]></category>
		<category><![CDATA[Visa Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22926</guid>
		<description><![CDATA[According to Standard and Poor’s latest realignment, Ciena Corp. (CIEN), the telecommunications equipment maker has been removed from the S&#38;P 500 index and has been included in the S&#38;P MidCap 400, replacing Blyth Inc. (BTH). Visa (V) will replace Ciena in the S&#38;P 500 Index. After the announcement, Ciena shares fell 6.64%, as negative investor sentiments loomed on the stock. The S&#38;P 500 Index includes companies with market capital of above $5 billion. Since Ciena has a market cap of $1 billion, it is no longer a representative of the market index and thus has been removed. Standard &#38; Poor&#8217;s added five other companies to its S&#38;P 500 Incorporatedluding Mead Johnson Nutrition Co. (MJN), which is being split off from Bristol-Myers Squibb Co. (BMY), Ross Stores Inc. (ROST), Cliffs Natural ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/15/cien-ciena-corporation-is-removed-from-the-sp-500/22926/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

